Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Symbiotica Speciality is a specialized pharmaceutical company headquartered in Bengaluru, India, focused on the development and manufacture of Active Pharmaceutical Ingredients (APIs). The company has established a significant niche in the production of steroids and hormones, operating facilities that adhere to international quality standards including WHO-GMP. Their product portfolio features a wide array of corticosteroids such as Dexamethasone, Prednisolone, and Hydrocortisone, which are utilized in treatments for respiratory, dermatological, and inflammatory conditions. In addition to its catalog of APIs, Symbiotica provides contract manufacturing and development services (CDMO) to global pharmaceutical partners. The company leverages advanced chemical synthesis capabilities to deliver high-purity ingredients for the global healthcare industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Symbiotica Speciality.